Back
Royal Bank of Canada Vs. Corcept Therapeutics Industry Stock Comparison
Buy
60
RY
Royal Bank of Canada
Last Price:
$115.16
Seasonality Move:
1.38%
Buy
73
CORT
Corcept Therapeutics
Last Price:
$79.38
Seasonality Move:
6.42%
Buy
60
Royal Bank of Canada (RY)
is a Buy
Is Royal Bank of Canada a Buy, Sell or Hold?
-
The current Royal Bank of Canada [RY] share price is $114.72. The Score for RY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
RY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
73
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
-
The current Corcept Therapeutics [CORT] share price is $83.81. The Score for CORT is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
CORT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RY Stock Price Chart
What is Royal Bank of Canada's stock price today?
-
The Royal Bank of Canada share price today is $114.72The current trend is relatively stagnant and RY is experiencing buying pressure, which is a positive indicator for future bullish movement.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $83.81The current trend is moderately bullish and CORT is experiencing selling pressure, which indicates risk of future bearish movement.
RY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.77 | Sell |
Relative Strength Index (14 RSI): | 49.78 | Sell |
Chaikin Money Flow: | 856745 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (111.71 - 116.47) | Buy |
Bollinger Bands (100): | (115.82 - 124.16) | Sell |
CORT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 22.57 | Buy |
Relative Strength Index (14 RSI): | 60.19 | Buy |
Chaikin Money Flow: | -2270831 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.3 - 75.72) | Buy |
Bollinger Bands (100): | (50.37 - 68.35) | Buy |
RY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 114.6 | Buy |
20-day SMA: | 113.5 | Buy |
50-day SMA: | 117.23 | Sell |
200-day SMA: | 117.74 | Sell |
8-day EMA: | 114.03 | Buy |
20-day EMA: | 114.43 | Buy |
50-day EMA: | 116.46 | Sell |
200-day EMA: | 115.78 | Sell |
CORT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 72.02 | Buy |
20-day SMA: | 62.56 | Buy |
50-day SMA: | 63.86 | Buy |
200-day SMA: | 48.45 | Buy |
8-day EMA: | 72.03 | Buy |
20-day EMA: | 46.17 | Buy |
50-day EMA: | 23.32 | Buy |
200-day EMA: | 6.62 | Buy |
Royal Bank of Canada Earnings Growth & RY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.14 per share, an increase this year of $0.82 per share, and an increase next year of $0.66 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.29 per share, and an increase next year of $1.64 per share.
Royal Bank of Canada Technical Analysis
Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corcept Therapeutics Technical Analysis
Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |